General
Australia’s Oxford-AstraZeneca COVID-19 vaccine choice questioned as experts highlight ‘shaky’ science
Sitting in his home in New York, Geoff Porges is a long way from his family in Orange, in regional New South Wales.
In fact, during 2020, it has never felt further away for Dr Porges, a vaccine expert of 25 years and a director of therapeutics research at the one of the world’s leading healthcare investment banks.
And although he may be a long way away, this week Dr Porges made comments that reverberated back to his country of birth.
LIVE UPDATES: Read our blog for the latest news on the COVID-19 pandemic.
On Monday night Australian time, the AstraZeneca-Oxford University vaccine candidate, one of the COVID-19 vaccines the Australian Government committed to in a multi-billion-dollar deal, released its first interim results from its phase 3…
-
Noosa News12 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business14 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Noosa News14 hours agoBrisbane news live: 80,000 green bins rolled out | Residents told to prepare for ‘violent’ summer storms | Council declares water safe for swimming despite dead fish
-
Business15 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today